Delivery Order 36F79721D0239-36C26124N0489
Award Date 3/11/24
Potential Completion Date 6/11/24
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Travere Therapeutics, Inc. was awarded a $11,280.58 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order was issued under Travere's Pharmaceuticals and Drugs General Services Administration Federal Supply Schedule contract to supply FILSPARI to VA medical facilities located in San Diego, California. No set-aside designation was applied to this award. Travere Therapeutics holds several...
- Travere Therapeutics, Inc. has been awarded a $11,125.32 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to supply Thiola 100 MG pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) with no set-aside applied, and performance will occur in San Diego, California by March 12, 2024. Travere specializes in developing therapies for...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The $212,584.00 firm fixed-price purchase order is for the delivery of pharmaceutical drugs, with a period of performance ending on September 30, 2025. Travere Therapeutics holds a Federal Supply Schedule (FSS) contract with the VA as well as two Blanket Purchase Agreements (BPAs) specifically covering the procurement...
- The Department of Veterans Affairs (VA) has awarded Travere Therapeutics, Inc. a firm fixed price delivery order to provide THIOLA 100 MG, a pharmaceutical product used to treat rare diseases affecting kidney and liver function. This award is issued against Travere's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, which serves as the primary vehicle for these types of orders. The delivery order has a potential value of $11,125.32 and a completion date of...
- This is a federal contract award issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Travere Therapeutics, Inc. The contract is for the delivery of the pharmaceutical product Filspari, with a ceiling value of $11,280.64 and a completion date of December 18, 2024. The contract is a Delivery Order under Travere's Federal Supply Schedule (FSS) contract with the VA for Pharmaceuticals and Drugs (FSS-61-IB). Additionally, Travere holds two...
- This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to Travere Therapeutics, Inc. for the supply of the pharmaceutical drug Thiola. The delivery order, valued at $124,160.04, was issued under Travere Therapeutics' Pharmaceuticals and Drugs GSA Schedule contract. Travere Therapeutics is a biopharmaceutical company that provides specialty pharmaceuticals to government agencies, including the...
- The U.S. Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Travere Therapeutics, Inc., a biopharmaceutical company that specializes in rare disease therapies. The contract, valued at $11,125.32, is for the supply of the pharmaceutical drug Thiola 100 mg. This delivery order is placed against Travere Therapeutics' Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA. Travere Therapeutics also holds a $25 million Blanket...
- Travere Therapeutics, Inc. was awarded a $25,983.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order, which has no set-aside designation, is for the delivery of 100 mg Thiola to the place of performance in San Diego, California. The order has a completion date of March 28, 2023 and was awarded on March 24, 2023 under Master GSA...
- This is a firm fixed-price delivery order award to Travere Therapeutics, Inc., a biopharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21. The contract is for the supply of Travere's specialty pharmaceutical product Filspari 400mg, which is used to treat rare diseases affecting kidney and liver function. The award has a ceiling value of $7,354.26 and a period of performance through September 30, 2024. Travere Therapeutics holds a Federal Supply...
- This is a federal contract award to Travere Therapeutics, Inc., a biopharmaceutical company, for the delivery of the pharmaceutical product Thiola 100 mg. The contract, valued at $11,125.32, was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5) on August 26, 2024, with an ultimate completion date of August 27, 2024. The contract is a firm fixed price delivery order issued under Travere's Federal Supply Schedule (FSS) contract with the VA for...